Results 21 to 30 of about 52,877 (267)

Ivermectin in Acute Renal Injury Induced by Ischemia-Reperfusion: An Experimental Study in Wistar Rats [PDF]

open access: yesRevista Brasileira de Enfermagem
Objectives: to assess the effect of ivermectin in an experimental model of ischemia-reperfusion as a risk factor. Methods: twenty adult male Wistar rats were randomized into the following groups: Sham: surgical simulation without clamping of the renal ...
Raphael Cuencas Budini   +6 more
doaj   +5 more sources

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit. Objective To determine whether ivermectin is an efficacious treatment for mild COVID-19.
Eduardo López-Medina   +18 more
semanticscholar   +1 more source

In vitro larvicidal activity of ivermectin and povidone-iodine against Oestrus ovis.

open access: yesPLoS ONE, 2021
PurposeTo assess the in vitro larvicidal activity of ivermectin and povidone-iodine (PVP-I) against Oestrus ovis, the most frequent cause of external ophthalmomyiasis.MethodsL1 O.
Giuseppe D'Amico Ricci   +6 more
doaj   +2 more sources

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2023
Importance It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients with mild to moderate COVID-19.
S. Naggie   +248 more
semanticscholar   +1 more source

Differential Effect of Ivermectin on Intestinal Helminths in Multimmate Mouse (Mastomys natalensis). [PDF]

open access: yesVet Med Sci
Mastomys natalensis harbours gastrointestinal helminths of public health and food‐safety importance. This study identified five helminth taxa and assessed faecal egg counts after a single ivermectin dose. Egg counts declined substantially in treated rodents but changed little in controls over eight weeks.
Thomas C   +9 more
europepmc   +2 more sources

Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug".

open access: yesEuropean journal of medicinal chemistry, 2023
Parasitic diseases still pose a serious threat to human and animal health, particularly for millions of people and their livelihoods in low-income countries.
Michał Sulik   +3 more
semanticscholar   +1 more source

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
C. Bramante   +36 more
semanticscholar   +1 more source

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

open access: yesEClinicalMedicine, 2021
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients.
Carlos J. Chaccour   +23 more
semanticscholar   +1 more source

Ivermectin for preventing and treating COVID‐19

open access: yesCochrane Database of Systematic Reviews, 2021
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory ...
Maria Popp   +7 more
semanticscholar   +1 more source

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines

open access: yesAmerican Journal of Therapeutics, 2021
Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.
A. Bryant   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy